# Viridian Therapeutics, Inc. (VRDN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VRDN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 425.0K | $ -232.02M | $ -226.31M | $ 242.88M | $ 662.10M |
| 2025 | $ 72.54M | $ -350.79M | $ -283.51M | $ 50.69M | $ 722.17M |
| 2024 | $ 317.4K | $ -283.74M | $ -244.72M | $ 21.10M | $ 671.64M |
| 2023 | $ 339.5K | $ -257.05M | $ -200.11M | $ 21.05M | $ 442.02M |
| 2022 | $ 1.98M | $ -145.08M | $ -105.72M | $ 5.26M | $ 395.06M |
| 2021 | $ 3.52M | $ -94.39M | $ -65.28M | N/A | $ 187.72M |
| 2020 | $ 1.34M | $ -141.04M | $ -37.94M | N/A | $ 120.04M |
| 2019 | $ 5.76M | $ -54.05M | $ -46.65M | $ 8.30M | $ 15.75M |
| 2018 | $ 11.08M | $ -43.19M | $ -36.04M | $ 10.30M | $ 51.34M |
| 2017 | $ 5.39M | $ -35.72M | $ -38.28M | $ 9.92M | $ 38.51M |
| 2016 | $ 4.59M | $ -17.44M | $ -10.15M | $ 1.05M | $ -326.0K |
| 2015 | $ 3.56M | $ -15.91M | $ -9.86M | $ 1.11M | $ 10.41M |
| 2014 | $ 6.10M | $ -11.15M | $ -3.50M | N/A | $ 5.99M |
| 2013 | $ 6.14M | $ -3.07M | $ -1.67M | $ 697.1K | $ 2.03M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.37 |
| Liabilities / Eq | 0.66 |
| Current Ratio | 16.95 |

## Other views

- [Metrics](https://sponda.capital/en/VRDN.md)
- [Charts](https://sponda.capital/en/VRDN/charts.md)
- [Compare](https://sponda.capital/en/VRDN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.